• HyperTrap Heparin HP: Evidence and Scope

  2026-10-17

  The HyperTrap Heparin HP Column is documented by APExBIO as a preloaded affinity column containing HyperChrom Heparin HP Agarose. Its stated mechanism is ligand-mediated retention of biomolecules with affinity for immobilized heparin. The product page identifies potential application classes and material properties, but provides no identity-matched study, chromatograms, binding constants, recovery data, comparative statistics, or independent validation. Accordingly, the product information supports a bounded identity and mechanism overview, not claims of demonstrated purification performance.

• CNQX and the Unresolved Chemerin–PVN Relay

  2026-10-16

  A 2024 rat study used CNQX as a pharmacological comparison to assess whether AMPA/kainate receptors in the paraventricular nucleus contributed to chemerin-9-induced sympathetic activation. The reported contrast with MK-801 supports a preferential role for NMDA signaling in that circuit, but the result does not establish that AMPA/kainate receptors are irrelevant across brain regions, physiological states, or measurement contexts.

• 3 sgRNA Scrambled Cy5 Label: Evidence Boundaries

  2026-10-16

  The APExBIO catalog designation identifies three low-purity, Cy5-labelled scrambled sgRNA preparations at 3 nmol each. It supports a limited interpretation involving fluorescent detection of labelled material, but provides no sequence, nuclease context, integrity data, functional validation, or matched research evidence.

• Biotin Alkyne: Evidence and Scope

  2026-10-15

  APExBIO lists Biotin alkyne as product A8021, but the linked product page provides no description or identity-matched research evidence. The name supports only a cautious, conceptual interpretation as a biotin-associated affinity motif combined with an alkyne functional handle; it does not establish the exact structure, mechanism, performance, or suitability of this specific product.

• Laurdan: A Proportionate Membrane Probe Overview

  2026-10-15

  APExBIO documents Laurdan as a membrane-permeable fluorescent probe whose spectral response is described as sensitive to membrane hydration and lipid packing. Its generalized polarization readout is presented as a comparative indicator of membrane physical state, phospholipid phase, and lipid-domain organization. Because no identity-matched research paper is available here, these claims define a documented product scope rather than independently validated performance, biological effects, thresholds, or formulation-specific outcomes.

• Probenecid: Mechanism and Evidence Boundaries

  2026-10-14

  Probenecid, also identified as 4-(dipropylsulfamoyl)benzoic acid, is described by APExBIO as an inhibitor of organic anion transporters, multidrug resistance-associated proteins, and pannexin-1 channels. The available product description reports chemosensitization in resistant tumor-cell contexts, modulation of MRP protein abundance, and neuroprotection-associated findings in rat ischemia/reperfusion models, but no identity-matched primary paper, effect sizes, sample sizes, or independent validation are available here.

• Selonsertib in Lupus Nephritis Research

  2026-10-14

  A 2024 preclinical study links GS-4997-mediated ASK1 pathway inhibition with reduced tubulointerstitial injury in lupus-prone mice and an inflammatory tubular-cell model. The findings support further investigation of ASK1-related inflammation and fibrosis signaling, but they do not establish clinical efficacy, safety, or treatment value in people with lupus nephritis.

• Reserpine: Identity and Evidence Scope

  2026-10-13

  The available record supports a supplier-reported identity and broad research positioning for Reserpine, but it contains no matched paper or independent study evidence. Its proposed scope includes neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology research; applicability to hypertension or other settings cannot be assessed from the supplied materials.

• Proteasome Inhibition and Viral RIPK3 Control

  2026-10-13

  The supplied study links an orthopoxvirus protein, vIRD, to SCF-dependent degradation of RIPK3 and altered necroptosis, inflammation, replication, and mortality in experimental models. The evidence supports a mechanistic relationship, but it does not constitute a head-to-head comparison of proteasome inhibitors or establish that Clasto-Lactacystin β-lactone was used in the work. Important gaps remain around model generalizability, pathway specificity, and translation beyond the studied viral systems.

• MLN2238 and the CRTC–CREB Stress Response

  2026-10-12

  MLN2238 is a reversible proteasome β5 subunit inhibitor used conceptually to study proteotoxic stress. A supplied Drosophila study links proteasome inhibition to ROS–JNK activation and CRTC–CREB-dependent transcription, while model limitations prevent direct extrapolation to human disease or clinical treatment.

• Arrb2, 6-ketoLCA, and Liver Ischemic Injury

  2026-10-12

  A source-grounded overview of a 2026 study linking hepatocyte Arrb2 to 6-ketoLCA production, M2-like macrophage responses, and reduced hepatic ischemia–reperfusion injury, with emphasis on evidence boundaries and translational limitations.

• ACSL4 Links Fatty Acid Oxidation to Decidualization

  2026-10-09

  The reference study identifies ACSL4 as a regulator of endometrial decidualization whose key contribution appears to be activation of fatty acid β-oxidation rather than lipid droplet accumulation. Using human and mouse tissues, endometrial stromal cell models, and implantation experiments, the authors connect ACSL4-dependent lipid utilization with decidual cell differentiation and embryo implantation, while also defining important limits for interpreting MPA-based models.

• Nystatin (Fungicidin): Evidence, Mechanism, and Limits

  2026-10-09

  Nystatin is best understood as an ergosterol-targeting polyene antifungal, while the supplied reovirus study provides a useful boundary case for interpreting claims about antiviral activity. This overview compares the provenance and strength of the available evidence, discusses conceptual research applications, and clarifies why findings from Candida, Aspergillus, and grass carp reovirus models should not be treated as interchangeable.

• Surface-Cleaned Black Phosphorus in AKI

  2026-10-08

  A 2026 Theranostics study reports that surface-cleaned black phosphorus nanosheets reduce oxidation, accumulate in injured kidneys, and modulate the ferroptosis–immune axis in acute kidney injury. The work links labile-iron sequestration with reduced lipid peroxidation, tubular injury, and macrophage inflammatory activation, while remaining preclinical and model-dependent.

• Methyl-β-cyclodextrin: Product Overview

  2026-10-08

  Methyl-β-cyclodextrin (SKU C6939) is an APExBIO-listed research reagent associated with conceptual studies of membrane lipids, cholesterol, and membrane organization. No matched paper evidence is available.

8656 records 1/578 page Next 12345 下5页 Last page